How does cancer spread to other parts of the body?
All cancers begin in a single organ or tissue, such as the lungs or skin. When these cancers are confined in their original organ or tissue, they are generally more treatable.
Feb 1, 2024
0
47
Pathologic Function: Metastasis
Medical news and research articles
Five counterintuitive ways scientists are approaching cancer research to improve treatment and prevention
How researchers conceptualize a disease informs how they treat it. Cancer is often described as uncontrollable cell growth triggered by genetic damage. But cancer can also be seen from angles that emphasize mathematics, evolutionary ...
Nov 2, 2023
0
26
Editorial: Subpopulations of AIB1-expressing breast cancer cells enable invasion and metastasis
A new editorial paper titled "Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis" has been published in Oncotarget.
Sep 6, 2023
0
66
Scientists identify cellular signaling pathway as key player in metastasis
A team of scientists at the Sloan Kettering Institute have identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after ...
Mar 29, 2023
0
850
New clue discovered as to how and why cancer cells spread
An international team of researchers has uncovered a new mechanism that enables cancer cells to move throughout the body, providing a potential new target to stop metastasis, which is responsible for 90 percent of cancer ...
Dec 5, 2022
0
67
Metastatic cancers adapt their metabolism to the tissue in which they grow
Cancer that splits and develops in new organs around the body becomes significantly more difficult to fight. Now, researchers at Chalmers have shown that these metastatic cancers, that spread from the original, adapt their ...
Nov 17, 2022
0
90
Multi-modal AI models for intermediate- to high-risk localized prostate cancer
NRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910, and 0126) to develop and validate multi-modal intelligence models (MMAI) ...
Oct 25, 2022
0
38
